Keros Therapeutics (KROS) Operating Leases (2019 - 2026)
Keros Therapeutics (KROS) recorded Operating Leases of $13.13 million in Q2 2026, down 16.5% from $15.72 million a year earlier.
Powered by 
Analysis
Keros Therapeutics (KROS) Operating Leases (2019 - 2026) Analysis & Trends
At the end of FY2025, Keros Therapeutics reported Operating Leases of $14.48 million, down 14.3% from FY2024.
- Annual Operating Leases has a five-year compound annual growth rate of 98.0% (FY2020 to FY2025).
- Across earlier years, Operating Leases came in at $16.88 million in FY2024 (+25.6%), $13.44 million in FY2023 (+4.9%), $12.81 million in FY2022 and $231,000 in FY2021 (-51.5%).
- The Q2 2026 figure is the lowest quarterly Operating Leases since Q2 2024.
- On a year-over-year basis, Operating Leases rose in four of the last seven quarters, with growth averaging 7.9%.
- Peak year-over-year performance for Operating Leases in the last five years was growth of 27.2% in Q3 2024, against a decline of 51.5% in Q4 2021 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,138.33 Bn | 1,106.91 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 618.82 Bn | 537.35 Bn | 17.26 Bn |
| 3 | AbbVie | 503.36 Bn | 476.47 Bn | 12.70 Bn |
| 4 | Merck | 369.59 Bn | 323.96 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.57 Bn | 262.56 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.25 Bn | 234.94 Bn | 12.86 Bn |
| 7 | Amgen | 237.35 Bn | 192.75 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.27 Bn | 165.47 Bn | 6.22 Bn |
| 9 | Pfizer | 170.03 Bn | 116.68 Bn | 10.94 Bn |
| 10 | Keros Therapeutics | 220.97 Mn | -1.71 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.13 Mn |
| Dec 31, 2025 | 14.48 Mn |
| Sep 30, 2025 | 15.11 Mn |
| Jun 30, 2025 | 15.72 Mn |
| Mar 31, 2025 | 16.31 Mn |
| Dec 31, 2024 | 16.88 Mn |
| Sep 30, 2024 | 17.43 Mn |
| Jun 30, 2024 | 12.86 Mn |
| Mar 31, 2024 | 13.15 Mn |
| Dec 31, 2023 | 13.44 Mn |
| Sep 30, 2023 | 13.70 Mn |
| Jun 30, 2023 | 13.95 Mn |
| Mar 31, 2023 | 13.99 Mn |
| Dec 31, 2022 | 12.81 Mn |
| Dec 31, 2021 | 231,000.00 |
| Sep 30, 2021 | 453,000.00 |
| Jun 30, 2021 | 242,000.00 |
| Mar 31, 2021 | 361,000.00 |
| Dec 31, 2020 | 476,000.00 |
| Sep 30, 2020 | 586,000.00 |
API Access
Keros Therapeutics Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=KROS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "KROS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=KROS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();